Aytu Biopharma, Inc
AYTU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385818
No open-market purchases or sales by Aytu Biopharma, Inc insiders were filed in the last 90 days; 38 institutions reported holding it in 13F filings for Q2 2026, worth $8.25M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Aytu Biopharma, Inc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 61 | 49 | −12 |
| Shares | 5.18M | 4.25M | −936.0K (−18.1%) |
| Value | $26.0M | $12.2M | −$13.7M (−52.9%) |
New holders (2)
Institutions that held Aytu Biopharma, Inc at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Creative Planning | 13,000 | $37.0K | 0.00% |
| Federated Hermes, Inc. | 664 | $2.00K | 0.00% |
Sold out (14)
Institutions that held Aytu Biopharma, Inc at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Armistice Capital, LLC | 1,342,378 | $6.72M |
| Virtu Financial LLC | 101,805 | $510.0K |
| Ergoteles LLC | 75,472 | $378.0K |
| Tibra Equities Europe Ltd | 60,100 | $301.0K |
| Squarepoint Ops LLC | 34,487 | $173.0K |
| Pinz Capital Management, LP | 21,400 | $107.0K |
| Deutsche Bank AG | 20,800 | $104.0K |
| Jane Street Group, LLC | 15,720 | $78.0K |
| Geneos Wealth Management Inc. | 783 | $3.00K |
| New York State Common Retirement Fund | 194 | $1.00K |
| Bellevue Asset Management, LLC | 260 | $1.00K |
| Kelly Financial Services LLC | 611 | $122 |
| Ellevest, Inc. | 70 | $0 |
| CVA Family Office, LLC | 1 | $0 |